Reimagining the regulation of informal pharmaceutical markets: The importance of pragmatic expertise and improvisation in Nigeria

Drug-induced upper gastrointestinal bleeding: A real-world pharmacovigilance study

MHRA Drug Safety Update: Falsified Mounjaro KwikPen 15mg pre-filled pens

Puberty blockers: Controversial trial paused over safety concerns

Redefining polypharmacy: Shifting from drug counts to patient-centered clinical appropriateness

Long‐Term Adherence and Drug Utilisation Patterns Among New Users of Anti‐Hyperlipidemic Monotherapy: Development of a Risk Prediction Model

Cómo la Industria Farmacéutica Influye en la Producción de Evidencias Científicas: Manipulación de Investigaciones y Escritura Fantasma (ghostwriting)

Systematic modeling predicts synergistic and safe drug combinations for parasitic diseases

Prospective Study of Adverse Drug Reactions in Patients with Bipolar Disorder at a tertiary centre

Potential utility of social media in pharmacovigilance to identify adverse events and safety signals: a scoping review

Aquatic ecotoxicology in a climate change scenario to support ecopharmacovigilance of veterinary antibiotics

Digital medicine for infectious diseases

Comparison of Adverse Events Associated With Six Common Antibiotics in Lower Respiratory Tract Infections Using the United States Food and Drug Administration Adverse Event Reporting System

Contributions of Pharmacovigilance to the Understanding of Risks Associated with Ibuprofen: Descriptive and Disproportionality Analysis Using FAERS Data

Artificial Intelligence for Drug Safety Across the Lifecycle and Decision Type: A Scoping Review

Comparative disproportionality signals for methotrexate monotherapy versus methotrexate combined with hydroxychloroquine, leflunomide, or sulfasalazine in rheumatoid arthritis: newly highlighted signals evaluated using drug information safety profiles

Dosis letal: cómo se mide la seguridad de un medicamento

Potential risk signals for drug-related osteomyelitis: a comprehensive disproportionality analysis based on the FDA Adverse Event Reporting System (FAERS) database

A pharmacovigilance analysis of carbapenem-related utilizing the FDA adverse event reporting system (FAERS) database from 2013 to 2025

Exploratory analysis of real-world use and safety of traditional Korean medicine in pediatric epilepsy: A retrospective observational study

Prenatal exposure to antiseizure medications and risk of autism spectrum disorder in offspring: an integrated pharmacovigilance and two-sample mendelian randomization study

Navigating drug–drug interactions with apalutamide

Artificial intelligence-based incident analysis and learning system to enhance patient safety and improve treatment quality

Selective oestrogen receptor modulators and Alzheimer´s disease: a real-world pharmacovigilance study

Unveiling the hidden risks of nanomedicine-based drug delivery: a comparative evaluation of drug safety profiles of liposomal irinotecan and conventional irinotecan

Empowering citizens to spontaneously report suspected adverse drug reaction: Systematic literature review of interventions and their impact

Assessing safety trends of withdrawn medications: A data-driven pharmacovigilance approach using growth models

Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases—An update

Fondos Rotatorios: un mecanismo clave para garantizar la disponibilidad y seguridad de vacunas y medicamentos en el Perú

Navigating Polypharmacy: A Patient-Focused Guide to Safer Medication Use

What if most medications were sold over-the-counter?

Complex Link Between Drug Prices and Health Plan Coverage

Anabolic Steroid Misuse Damages Heart, Liver, Kidneys, and Brain

Chlorhexidine vs Povidone-Iodine and Incidence of Catheter-Related Infections. A Systematic Review and Meta-Analysis

Mechanisms Are Emerging for COVID-19 Vaccine−Associated Myocarditis

Using the advantages and avoiding the risks – a public survey about the challenges of online purchases of medicines

Disparities and trends in drug-related adverse reaction mortality in the United States, 1999–2020

Safety communication unveiled: A comprehensive bibliometric analysis spanning two decades (2001-2023)

Subacute Cutaneous Lupus Erythematosus Following COVID-19 Vaccination: A Case Report after BNT162b2 Vaccine and Literature Review

Guideline Adherence of Perioperative Antibiotics and Surgical Site Infections in Noncardiac Surgery

Pharmacist Intervention for Safer Prescribing in Patients With Type 2 Diabetes at High Risk. A Randomized Clinical Trial

Farmacovigilância: causas da subnotificação por profissionais de saúde e estratégias para redução

Performance of the Self-Controlled Case Series for Drug Safety Signal Detection: A Multi-Database Study

Comparing Paracetamol and Ibuprofen Safety in Infant Care

Desinformación en salud: un desafío estructural que exige una estrategia transversal

Drugs associated the most with Retroperitoneal Fibrosis: assessment of the 1969-2025 Food and Drug Administration (FDA) pharmacovigilance database

Good News for Patients Worried About Statin Side Effects: Study Finds Most Never Happen

Statin safety: when warnings outlive the evidence

EMA recommends withdrawal of marketing authorisations for levamisole medicines

The ASCEND Project (2020-2023): Strengthening clinical trial ethics review and pharmacovigilance capacity in Tanzania mainland and Zanzibar

AI-Enabled Surveillance and Modelling for Counterfeit Botulinum Toxin A: Risk Projection, Patient Safety, and Systemic Reform of Pharmacovigilance

Development and validation of a machine learning stratified prediction model for early warning of anti-tuberculosis drug-induced liver injury risk based on real-world data: a retrospective cohort study

20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys

Efficacy and safety of different inhaler types for asthma and chronic obstructive pulmonary disease. a systematic review and meta-analysis

Biochemical profiling provides a low-cost and globally accessible method to detect falsified vaccines and insulin

A framework for enhancing pharmaceutical integrity and patient safety: novel mobile health solution integrating smart packaging and computer vision

Drugs Associated with Pediatric Cataracts: A Real-World Pharmacovigilance Study

El Hospital Regional de Málaga alerta del reto del Paracetamol entre menores, que puede causar la muerte

A Review Harnessing Artificial Intelligence for Enhanced Pharmacovigilance

A Short Overview of Using Artificial Intelligence in Pharmacovigilance

Analysis of the Adverse Event Profiles of Medications for Alcohol Use Disorder: Insights from a Japanese Pharmacovigilance Database

Early Detection of Absurdity Signals in Pharmacovigilance: A Machine Learning Ensemble Approach to Identify Rare Adverse Drug Reactions

Artificial intelligence-based incident analysis and learning system to enhance patient safety and improve treatment quality

Further information on Post authorisation monitoring – Pharmacovigilance

Ministerio de Salud intensifica lucha frontal contra la falsificación de medicamentos

Drug-drug interaction, adverse drug reaction and their determinants among adult hypertensive patients; Multicenter study in Ethiopia

Age and Gender Heterogeneity in Adverse Drug Reactions Associated with Hemp Use: Evidence from the FDA Pharmacovigilance Data in the Last Two Decades

Artificial Intelligence and Machine Learning in Pharmacovigilance: A Systematic Review of Models for Drug Safety in Polypharmacy

Evaluating adverse events reported for non-steroidal anti-inflammatory drugs in osteoarthritis: a real-world pharmacovigilance study

Medication Concerns: Driving Factors in High-Risk Adults

La AEMPS informa del cambio de dosificación de Rybelsus (semaglutida) y los posibles errores de medicación

El CGCOF y la AEMPS lanzan una campaña para fomentar la notificación de reacciones adversas de los medicamentos

Safety population size and duration of exposure prior to approval of new medicines: A database analysis of medicines centralised approved in the European Union between 2011 and 2023

Veterinary drug residues in food: what’s the latest in the EU?

 

IXCHIQ Chikungunya vaccine: updates to restrictions of use following safety review

Las especialistas en Farmacología Clínica, claves para garantizar la seguridad de los medicamentos y la equidad en los ensayos clínicos

What drugs are safe during pregnancy? There’s a shocking lack of data

Impact of the amended CIR 520/2012 to UK authorised products

Updates to CIR 520/2012 – Information for UK Marketing Authorisation Holders

Clinicians and pharmacists – Are your patients aware of the risks of buying melatonin online?

Europa se estanca en la reducción de residuos de medicamentos veterinarios: más controles, pero mismos resultados

EsSalud refuerza la vigilancia de medicamentos y dispositivos médicos para prevenir riesgos en pacientes

Phosphorescent supramolecular systems for medicine anticounterfeiting

Seis boticas clausuradas por venta irregular de medicamentos

Prescribing Patterns of Potentially Inappropriate CNS-Active Medications in Older Adults

Large language models-powered agentic AI design and implementation in pharmacovigilance—a narrative review

Older Patients Have Specific Risks for GLP-1 Use

Artificial Intelligence in Food Allergy and Drug Allergy

Respiratory drugs and psychiatric adverse events in children and adolescents: a pharmacovigilance study based on the FAERS database

Proton Pump Inhibitors and Disproportionate Reporting of Acute Kidney Injury and Tubulointerstitial Nephritis: A FAERS Pharmacovigilance Study, 2020–2025

Safety Assessment of Budesonide/Formoterol: Real-World Pharmacovigilance Analysis Using the FAERS, JADER, and CVAR Databases

Real-World Sodium Fluoride Safety Signals: Dual-Database Pharmacovigilance

Assessing patient risk, benefit, and outcomes in drug development: a decade of sorafenib clinical trials

La AEMPS informa sobre el riesgo de acontecimientos adversos en animales de compañía por contacto con medicamentos hormonales tópicos de humanos

Computational modelling and network medicine in drug toxicology and clinical pharmacovigilance

When Silence Signals Safety: Governance and Responsibility in AI-Enabled Prescription Verification

Update of the statement on safety of cannabidiol as a novel food

Por qué la seguridad está redefiniendo la política del medicamento

FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs

Adverse Drug Reactions to Biologic Drugs in the Treatment of Psoriasis

Evaluating Pharmacists’ Role In Veterinary Medication Management and Education

Drug Safety Agents Using Graphs and Ontologies

Signal to Safety: Unpacking the Pharmacovigilance Program of India (PVPI)

Suspect screening strategy reveals that illegal addition of drugs to fishery inputs is the main cause of drug residue problems in quality and safety of aquatic products in China

Excipient toxicity and tolerability in self-emulsifying drug delivery systems: insights from cell-based assays

Prevalence and Trends of Adulterants Detected in Products Sampled by Sarawak Pharmacy Enforcement Branch

Disproportionality analysis of semaglutide-associated bile-duct cancer: A vigibase study

Drug-associated tongue discoloration: a comprehensive assessment of USFDA adverse event reporting system using disproportionality analysis

Sex-disparate safety profile of Obinutuzumab: a pharmacovigilance analysis using the FDA adverse event reporting system

Rapid analytical screening of pharmaceuticals using UV-activated fluorescence fingerprints

Impact of Different Dosage Forms of Orally Administered Chinese Herbal Medicine on Treatment and Adverse Effect Estimates in Randomized Controlled Trials: A Meta-Epidemiological Study

Disproportionality analysis of drug-associated progressive multifocal leukoencephalopathy using spontaneous reports: A 20-year signal detection study based on the FAERS database

50 contenedores refuerzan la lucha contra el comercio ilegal de medicamentos vencidos o falsificados

Structure-Based Prediction of QT Prolongation Risk Using Graph Neural Networks: An Integrative Approach Combining In Vitro hERG Assays and Pharmacovigilance Data

Development of a non-genetic risk prediction model for allopurinol-induced severe cutaneous adverse drug reactions: a multicenter retrospective observational study

Artificial intelligence in pharmacy predicting adverse drug reactions

Impact of two decades of humanitarian and development assistance and the projected mortality consequences of current defunding to 2030: retrospective evaluation and forecasting analysis

Childhood Vaccinations: Public Health and Individual Rights

Antibiotic Use in Infancy May Set Path for Weight Gain

Comparative Safety of Advanced Therapies for Crohn Disease

Drug Used for Enlarged Prostate Tied to High Glaucoma Risk

A risk to child health: confusion and concern over changes to US vaccine policy

Four in ten cancer cases could be prevented globally

National and State Societal Costs of Schizophrenia in the US in 2024

Cancer Incidence and Mortality With Aspirin in Older Adults. Follow-Up of the ASPREE Trial

ADHD Treatment Linked to Higher Adult BMI, Slight Height Loss

Why Skin Toxicity Remains Common in Modern Cancer Therapies

Global pharmacovigilance analysis of antimicrobials used in periodontal therapy: safety profiles of minocycline, doxycycline, and chlorhexidine

Medication Errors: Year in Review

PHS urges caution following reports of increased harm from changes in Scotland’s drug supply

Fixed Drug Eruptions in Malagasy Children: Clinical Observations and Characteristics

An interpretable machine learning framework for adverse drug reaction prediction from drug-target interactions

Integrated precision medicine and artificial intelligence in healthcare

Development of a Data-Driven Prediction Model of Adverse Drug Reactions Using Large-Scale Medical Information and Machine Learning

How is AI developing in pharmacovigilance?

Digemid alerta sobre falsificación de Kitadol Migraña e incauta lotes: conoce cómo identificarlo

When I use a word . . . Artificial intelligence—predicting and detecting adverse drug reactions

Integration of materiovigilance in Unani medicine: A step towards patient safety

DEA Operation Meltdown Shuts Down Hundreds of Illegal Online Pharmacies

Adverse events related to buspirone: a real-world pharmacovigilance study using the FAERS database

Class-level drug safety surveillance in hospital practice: A pharmacovigilance analysis of 84 therapeutic subclasses from a South Asian tertiary care center

Safety Actions Common With Fast-Track Cancer Drugs

Beyond the Bookshelf: Transforming Drug Information Resources through Digital Innovation

Exploring adverse events associated with vosoritide monotherapy: Insights from the FDA Adverse Event Reporting System

Cardiac disorders associated with compound long-acting bronchodilators for inhalation: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database

Are We Missing Dangerous Drug Interactions? Pharmacist-Led Telehealth Raises Red Flags in Oncology Care

Pediatric IBD: Combination Therapy Linked to Increased Skin Infection Risk

Efficacy and safety of delayed thrombolysis for ischemic stroke within 4.5–24 h: A systematic review and meta-analysis of randomized controlled trials

Inteligencia artificial en medicina: una guía ética y práctica para la asistencia sanitaria, la investigación y la docencia

Overview of counterfeiting in performance-enhancing drugs used in enhanced bodybuilding

Preliminary Quality Evaluation of New Generic Brands of Ciprofloxacin

El Invima alerta sobre la venta ilegal de cápsulas “anti-alopecia”

We need a standardized North American acetylcysteine dosing regimen for the treatment of paracetamol (acetaminophen) poisoning

Reducing delays in time-critical medications for Parkinson's disease: a multifaceted, multiprofessional quality improvement project

FDA Requests Removal of Suicidal Ideation Warning From GLP-1 RA Medications

Rethinking anti-cancer drug discovery: the evolution from polypharmacy to unified drug units

Drug-associated deep vein thrombosis: a disproportionality analysis of the FDA adverse event reporting system (FAERS) database

Exploring factors affecting access to non-communicable disease medicines in low- and middle-income countries: a systematic review

Identifying and Resolving Drug-Related Problems in Geriatric Patients

Treating Pregnant and Lactating Women: Insights from Clinical Pharmacology

Adverse Drug Events Associated with Opioid Treatment for Pain After Motor Vehicle Crash

Evaluating the impact of border management strategies on illicit trade reduction in Kenya's Ooe stop border post of Busia

Bayesian Multiple Testing for Suicide Risk in Pharmacoepidemiology: Leveraging Co-Prescription Patterns

Drug-induced intestinal obstruction: insights from the FDA Adverse Event Reporting System

THE DEADLY CONSEQUENCES OF CONTAMINATED MEDICINE: A LOOK INTO THE KILLER COUGH SYRUP CASE

HPLC Quantification and Impurity Profiling of Counterfeit Sildenafil Tablets from the African Market

Management of adverse events in TB care and active TB drug safety monitoring

Vaccine-associated lupus and related organ involvements: A pharmacovigilance analysis of VAERS database 1990–2025

Drug rash with eosinophilia and systemic symptoms: descriptive analysis of pharmacovigilance

Social media data and its potential for pharmacovigilance: a comparative analysis of reported prevalences regarding drug-induced gingival overgrowth (DIGO)

Drug-related suicidal events in children and teenagers: Age-stratified insights from FAERS

Fading microscopic codes to protect pharmaceuticals from counterfeiting

RISK FACTORS FOR POTENTIAL DRUG-DRUG INTERACTIONS OF ANALGESICS IN HOSPITALIZED UROLOGICAL PATIENTS

Safety concerns over imported counterfeit melatonin products

Amoxicillin-Clavulanate-Induced Pityriasis Rosea: A Pharmacovigilance Case Report

Boletín sobre Seguridad de Medicamentos de Uso Humano. Noviembre de 2025

El Invima advierte riesgos para la salud visual por gotas oftálmicas sin autorización de comercialización

Medication Regimen Complexity and Patient-Reported Adverse Drug Events in Korean Community Pharmacies: A Cross-Sectional Study

Vaccine Pharmacovigilance in India: Systematic Approaches and Lessons from Mass Immunization Programs

A tri-scale in silico framework integrating pharmacovigilance and mechanistic modeling suggests tepotinib-associated acute kidney injury risk

Trends in Antipsychotic Drug Use in the United States, 2000–2016

Preventability of Adverse Drug Reactions to Anticancer Drugs: Insights from the Database of the Regional Drug Information and Pharmacovigilance Center

Evaluation of pharmacovigilance related knowledge, attitude and practice among healthcare professionals and students in a tertiary-care hospital: a cross-sectional study

Precision Medicine for Asthma: Tailored to its Severity and Endotype/Phenotype

A Noisy Signal? Geographic Bias in FAERS Reports Linking Paracetamol to Autism Spectrum Disorder

España no se queda un mes sin amoxicilina, el problema de suministro afecta solo a una presentación hospitalaria

Safety signals of amide local anesthetics in dentistry: a real-world data analysis

Vaccine hesitancy: an evolving challenge

Limited Evidence Supporting Melatonin Use in Most Children

La evaluación de medicamentos ‘off-label’ se cuadruplica

Designing an OCR-Based Medication Support System with Drug–Drug Interaction Alerts for Elderly

Efficacy and safety of anti-inflammatory drug-assisted treatment of symptoms in patients with schizophrenia: a meta-analysis

Unintentional benzodiazepine use and frequency of drug checking service utilization: a cross-sectional study

The influence, promise, and potential perils of artificial intelligence in veterinary medicine: a call for improved awareness and literacy

A Two-Year Pharmacovigilance Analysis of Adverse Drug Reactions Reported from a University Allergy Setting

Real-World Evidence and Signal Detection: Emerging Methodologies in Indian Pharmacovigilance Practice

JAK Inhibitors and Memory Impairment: Disproportionality Analyses in the WHO Global Pharmacovigilance Database, VigiBase

Overview of counterfeiting in performance-enhancing drugs used in enhanced bodybuilding

Efficacy and safety of treatment regimens for drug-resistant tuberculosis in different regions: a systematic review and meta-analysis

Analysis of drug-drug interactions between psychiatric drugs in spontaneous adverse drug reaction reports from EudraVigilance

Effect of a drug dosing safety bundle initiative to improve pediatric drug dosing by paramedics. Results of the Michigan Pediatric EMS Error Reduction Study (MI-PEERS)

Adverse Drug Reaction-Related Hospital Admissions and Adverse Drug Events and Their Association with Short- and Long-Term Health Outcomes in Older Adults

Status of evidence on efficacy and safety of Indian traditional medicine (Ayush) for COVID-19: a qualitative review and evidence map synthesis

Are We Missing Dangerous Drug Interactions? Pharmacist-Led Telehealth Raises Red Flags in Oncology Care

Isotretinoin – changes to prescribing guidance and additional risk minimisation measures

Risky CNS Drug Prescribing Persists in Older Adults

The Future of Drug Safety

Antiseizure Treatments and Liver Injury: Expect (and Prevent) the Unexpected

Safety Surveillance for Hepatitis A Vaccine using the US Vaccine Adverse Event Reporting System (VAERS) database

Anti-Tubercular Drug-Induced Liver Injury: Current Understanding and Emerging Directions

SPECTRA-based Detection of Drug-Induced Hepatotoxicity through Extracellular Vesicle Analysis

NSAID Drug Hypersensitivity in a US-Based Population: An Assessment of Quality of Life

Proposal to amend the Human Medicines Regulations 2012 to support the ongoing supply and deployment of vaccinations across the UK: consultation response

Drug-induced urinary incontinence in pediatric patients: A disproportionality analysis of the FDA Adverse Event Reporting System

A real-world signal detection analysis uncovering the safety profile of ketorolac tromethamine

Drug-Induced Liver Injury with Eosinophilia: A Case–Control Study Using Electronic Medical Records

South Africa’s collaborative answer to fighting substandard and falsified medical products

The Hidden Peril: Ecuador's Struggle with Substandard and Falsified Medicines

Safety profile of concizumab: A systematic review and meta-analysis of randomised controlled trials

Point-of-Need and Portable Sensing Strategies for Quality and Safety Assessment of Traditional Chinese Medicine Products: A Critical Analytical Review

Feds Say Chicago Nurse Sold Fake Ozempic: What Nurses Need to Know

Artificial intelligence in pharmacovigilance: toward real-time, explainable, and global drug-safety systems

Standardization and safety analysis of a polyherbal formulation used in traditional medicine for renal disorders

Safety and Outcomes of Rapid Drug Desensitization to Various Biologic Agents: A Multidisciplinary Experience

La Policía Nacional desarticula una organización criminal dedicada a la generación y distribución de recetas médicas falsas a través de Internet

Pastilles, només les necessaries

Signal Detection for Drug Safety Fusing Spontaneous Reporting System and Social Media

Radiopharmaceutical Safety

A Methodological Review of Simulation Studies Published in Pharmacoepidemiology and Drug Safety

Healthcare providers’ knowledge gaps and educational needs in addressing substandard and falsified oncology drugs: a scoping review

Medicamentos verdes: hacia una farmacia más sostenible

DESINFORMAÇÃO E HESITAÇÃO VACINAL: O IMPACTO DAS FAKE NEWS NA ADESÃO AO PNI EM UM MUNICÍPIO DE MINAS GERAIS

Healthcare providers’ knowledge gaps and educational needs in addressing substandard and falsified oncology drugs: a scoping review

Evitar errors de medicació és a les vostres mans

Exploring Adverse Drug Reactions and Their Social and Psychological Consequences

Resistance, Ineffectiveness, and Off-Label Use Related to Cephalosporins from the Reserve Group—A Pharmacovigilance Signal Detection Study on EudraVigilance Database

A multicenter evaluation of patients’ knowledge of adverse drug reactions

Automating Individualized Notification of Drug Recalls to Patients: Complex Challenges and Qualitative Evaluation

Pancreatitis induced by Peg-aspargase in children: a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS)

Unveiling the Limits of Anticholinergic Burden Scales: A Study of Adverse Drug Reactions in the French Pharmacovigilance Database

Risk of drug eruption associated with the use of tetracyclines, macrolides, and fluoroquinolones: real-world evidence from a pharmacovigilance study utilizing the FDA adverse event reporting system

A Critical Analysis of the Laws Regulating the Sale of Counterfeit Goods in Cameroon

Patient perspectives on drug recalls in the Netherlands: a qualitative study

Adverse Drug Reactions in Patients With Hepatic Impairment: A Cross-Sectional Study

Integrating Pharmacogenomics into the Beers Criteria: A Machine Learning-driven Risk Assessment Framework for Novel Gene Drug Interactions

Comparative Gynecological Safety of the Dual GIP/GLP-1 Receptor Agonist Tirzepatide vs. the GLP-1 Receptor Agonist Semaglutide: A Real-World Pharmacovigilance Analysis (2022–2025)

Pharmacovigilance in the Post-COVID Era: Lessons Learned and Paradigm Shifts from the Indian Experience

Signal mining and safety profile analysis of lapatinib: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database

MHRA statement on new review of paracetamol safety during pregnancy

Public Views About Opioid Overdose and People With Opioid Use Disorder

A CROSS-SECTIONAL STUDY ON PERCEPTIONS OF PHARMACOVIGILANCE AMONG UNDERGRADUATE MEDICAL STUDENTS FROM NORTHERN INDIA

A short communication on digital and smart pharmacology: A new frontier in personalized medicine

Perception and Acceptance of Generic Medicines Among Consumers: A Comparative Qualitative Study with Branded Drug

Color anti-counterfeiting quick response code: An enhanced authentication method via dual-spectral feature analysis

The association between colorectal cancer drugs and heart failure: a real-world pharmacovigilance study of the FAERS database

Perspective on Better Access to Data and Data Integration in Pharmacovigilance: Information from a Focus Group

FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications

Electronic Intervention for Patient-Managed Benzodiazepine Tapering. Randomized Clinical Trial

Incomplete Patient Medication Histories Pose a Significant Barrier to Finding the Best Treatment Choices in Outpatient Community Care

Postmarket Safety Actions for Novel Oncology Drugs Granted FDA’s Accelerated Approval

Pharmacovigilance Knowledge, Attitudes, and Practices Among Healthcare Professionals in Nepal: A Systematic Review

Real-world safety profile of roflumilast: a pharmacovigilance analysis using FDA adverse event reporting system and Canada vigilance database

Adverse Events After Metastases-Directed Stereotactic Radiotherapy and Biological Cancer Therapy

Nimesulide-Associated Generalized Bullous Fixed Drug Eruption: A Rare Pharmacovigilance Case Report

Work Hours, Stress, and Burnout Among Resident Physicians

Millions with dementia still prescribed drugs linked to falls and confusion

EMA and FDA set common principles for AI in medicine development

Large-Scale Counterfeit Pill Manufacturer Pleads Guilty

Incumplimientos a las Buenas Prácticas de Farmacovigilancia por parte de la firma BIOTENK S.A.

Mueren dos pacientes oncológicos en el Hospital de Burgos por un error en su medicación

Updated Labeling for Menopausal Hormone Therapy

Navigating Conflicting Vaccination Recommendations. Guidance for Clinicians

ANMAT inhibe preventivamente la firma Biotenk S.A

The global Dx AMR collaborative: an approach to strengthen the role of diagnostics in combating antimicrobial resistance

Patient-Centric Pharmacovigilance in India: Innovative Approaches to Adverse Event Reporting and Risk Communication

App-based therapy for female patients with urinary incontinence in Germany (DINKS): a single-blind, randomised, controlled trial

Prescribing Patterns of Potentially Inappropriate CNS-Active Medications in Older Adults

Medication Errors after Hospital Discharge among Families who use a Language other than English

The urgent need for African research collaboration on medicine quality

Improving Information Supplied with Gabapentinoids (Pregabalin/Gabapentin), Benzodiazepines and Z-Drugs

Comparative safety profiling of sodium zirconate cyclosilicate and patiromer using real-world FAERS data: A pharmacovigilance analysis

Regulatory Harmonization in Indian Pharmacovigilance: Convergence with Global Standards and Unique National Adaptations

Suicide adverse events associated with zopiclone and eszopiclone: A pharmacovigilance analysis based on FAERS, JADER and CVARD

Benefits and Risks of Herbal Medicine Use During Pregnancy on Offspring Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies

An Updated Comprehensive Pharmacovigilance Study of Drug- Induced Breast Cancer Based on FDA Adverse Event Reporting System Data

Exploring the Contributions of Gendered Social Factors to Sex Disparities in Adverse Drug Events

Drug-induced risk of depression: A 20-year real-world pharmacovigilance analysis based on the FAERS database

The Pharmacovigilance Landscape in China: Challenges and Strategies Exemplified by Zanubrutinib

Topically administered macrocyclic lactone products, including eprinomectin, demonstrate comparable neurological safety in cats based on pharmacovigilance data

Evolution and Impact of India's Pharmacovigilance Programme: A Decade of Progress and Challenges

Antipsychotic drug use during pregnancy and neonatal outcomes: a systematic review and meta-analysis

Ranuras y fraccionamiento en formas farmacéuticas sólidas (ISP, Chile) – CIME

Computational pharmacovigilance of Lifitegrast in dry eye disease using machine learning and network toxicology

Creating A Multi-Criteria Decision Analysis Tool to Enhance Value-Based Purchasing of Generic and Biosimilar Medications in Saudi Arabia: A Pilot Study

Evaluating COVID-19 Vaccine Masking and Unmasking Methods in Two National Pharmacovigilance Databases

Refined pharmacovigilance assessment of immune checkpoint inhibitors-related bullous pemphigoid: a multi-methodological approach utilizing FAERS database

Lucian Leape’s legacy for patient safety

Professor Sir Aziz Sheikh: Towards next-generation pharmacovigilance capabilities for the UK

Closed-loop medication safety management reduces inappropriate medication in elderly patients with rheumatic and immunologic diseases

Machine Learning Models Reveal New Risk Factors for Sub-/Supra-Therapeutic Concentrations of Sirolimus in Children with Vascular Anomalies

Context matters: Causality and global epidemiology of proton pump inhibitor safety

Adverse events associated with cyclophosphamide: A pharmacovigilance study using the FDA adverse event reporting system

La AEMPS advierte sobre los riesgos de manipular comprimidos o cápsulas

Prospective Audit and Feedback by Antibiotic Stewardship Teams to Reduce Antibiotic Overuse at Hospital Discharge

ADHD and Methylphenidate Use in Prepubertal Children and BMI and Height at Adulthood

The role of MedDRA in global pharmacovigilance and public health during COVID-19: pandemic preparedness and response

Medication adherence in epilepsy: the role of adverse drug reactions and patient knowledge-attitude-behavior

Assessing User Experience and Satisfaction with a Mobile Application for Drug Dosage Calculation—A Pilot Study

Pharmacokinetics and Drug Interactions

Treatment Modifications After Drug Shortages Among Primary Care Physicians

Temporal Patterns of Adverse Events Associated With Selective Serotonin Reuptake Inhibitors: A Global Pharmacovigilance Analysis of Early-Onset Versus Late-Onset Toxicity

Multidimensional Assessment of Neurological Adverse Reactions Related to PD‐1 Inhibitors: A Real‐World Pharmacovigilance Study

Risk factors for denosumab-related osteonecrosis of the jaw: a pharmacovigilance study using the U.S. FDA adverse event reporting system database

Drug resistance patterns and associated risk factors in pulmonary tuberculosis patients from selected hospitals in Ghana

Drug-Induced Pulmonary Toxicity in the Era of Immunotherapy and Biologics: A Narrative Review of Mechanism, Diagnosis, and Management

Comparative Safety of Fibrate Drugs: a Pharmacovigilance Study of Fenofibrate and Gemfibrozil

Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database

Management of Complications Following Botulinum Toxin Facial Injections: A Narrative Review

Prenatal Exposure to Acid-Suppressive Medications and Risk of Neuropsychiatric Disorders in Children

How to Get ChatGPT to Recommend Thalidomide to a Pregnant Woman

Real-World Evidence for Medicare Drug Price Negotiations

Hongo mortal y resistente a medicamentos se propaga en hospitales y asilos de EE.UU.: estos 27 estados han reportado casos

New antibiotic pill shows promise against drug-resistant gonorrhea

Falsificação de medicamentos no Brasil: Uma revisão

Burden and Determinants of Drug–Drug Interactions at Hospital Discharge: Warfarin as a Model for High-Risk Medication Safety

Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance

Melanosis Secondary to Drugs: A Real‐World Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)

Pharmacies expect new year weight-loss drug ‘surge’ as MHRA warns against criminal activity

The prevalence of adverse drug reactions to antiretroviral therapy and associated factors among pediatric patients living with HIV in sub-Saharan African countries: a systematic review and meta-analysis

Assessment of drug induced thyroid dysfunction risk using the FDA adverse event reporting system (FAERS)

Efficacy and safety of traditional Chinese medicine injections for older adults with community-acquired pneumonia: An evidence map

Drug Induced Skin Reactions in Hospitalized Patients: Epidemiology and Management

Drug-related hepatotoxicity risk in elderly patients with atrial fibrillation: insights from the nationwide Italian START registry

Safety and Pharmacogenetics of Oxycodone in Post-Cesarean Analgesia and Breastfeeding Dyads: A Proactive Approach to Precision Medicine

Characterization of ocular adverse events associated with crizotinib: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase

Complementary and Alternative Medicine-Induced Combined Hepatorenal Toxicity: A Case Report

Medicamento LASA: el riesgo de confundir nombres en la ciencia y la salud

Adverse drug reaction reporting and monitoring: A review of global practices

Pharmacovigilance and herbal medicines safety: a cross-sectional study of healthcare professionals’ knowledge, attitudes and practices in selected regions of Tanzania, 2021

Balancing Pain Relief and Safety: Gastrointestinal and Cardiovascular Risk Assessment in Nonsteroidal Anti-Inflammatory Drug Users and the Role of Gastroprotective Co-Therapy

Colegio de Farmacéuticos alerta aumento del ingreso ilegal de medicamentos por la frontera norte

Strengthening pharmacovigilance systems through post-vaccination surveillance in Nigeria: A narrative review

A review of the advances in insect evidence analysis for estimating postmortem interval and detecting drug toxicity

Análisis de causalidad de reacciones adversas mediante algoritmo de Naranjo en internados en un hospital

Are We Underestimating the Toxicity of Combination Immune Checkpoint Inhibitors? Real-World Evidence Challenging Current Guideline Predictions.

Safety and outcome of bedaquiline and delamanid-based longer oral regimen in Indian children less than 5 years with drug-resistant tuberculosis

Assessing the Safety of Medications During Lactation. Lactation safety

Adverse events associated with classic psychedelics and MDMA: A real-world population-based study using the WHO pharmacovigilance database (VigiBase®)

Drug-Induced Liver Injury Associated With Moxifloxacin: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System and a Real-World Retrospective Study

Medication-related adverse events in older Brazilians

Safety Comparison of Risk of Liver Dysfunction between Generic and Brand Statin Drugs Marketed in Japan: A Cohort Study Using MID-NET®

A novel antituberculosis agent exhibits potent clinical efficacy and good safety profile: an open-label, randomized-controlled, multicenter, phase 2a trial

Fear and Medical Misinformation Regarding Risk of Progression or Recurrence Among Patients with Breast Cancer

Lives to be saved by boosting access to drug overdose medication

MHRA urges public to avoid illegal online weight-loss medicines this New Year

Unanswered questions loom as Pondicherry refers multi-crore counterfeit medicine racket to CBI and NIA

Addressing Counterfeit Medicines and Community Risk: Insights from South African Spaza Shops

MHRA urges public to avoid illegal online weight-loss medicines this New Year

ADHD drugs don’t work the way we thought

Opioid Room of Horrors: a simulation approach to strengthen drug administration safety